104 related articles for article (PubMed ID: 25583073)
1. Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics.
Samy RP; Thwin MM; Stiles BG; Satyanarayana-Jois S; Chinnathambi A; Zayed ME; Alharbi SA; Siveen KS; Sikka S; Kumar AP; Sethi G; Lim LH
Biochimie; 2015 Apr; 111():30-44. PubMed ID: 25583073
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a phospholipase A2 from the venom of the Saw-scaled viper: Novel bactericidal and membrane damaging activities.
Perumal Samy R; Gopalakrishnakone P; Bow H; Puspharaj PN; Chow VT
Biochimie; 2010 Dec; 92(12):1854-66. PubMed ID: 20723574
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
[TBL] [Abstract][Full Text] [Related]
4. Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent.
Samy RP; Stiles BG; Chinnathambi A; Zayed ME; Alharbi SA; Franco OL; Rowan EG; Kumar AP; Lim LH; Sethi G
FEBS Open Bio; 2015; 5():928-41. PubMed ID: 26793432
[TBL] [Abstract][Full Text] [Related]
5. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.
Lin MC; Hui CF; Chen JY; Wu JL
Peptides; 2013 Jun; 44():139-48. PubMed ID: 23598079
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
7. Purification, characterization and bactericidal activities of basic phospholipase A2 from the venom of Agkistrodon halys (Chinese pallas).
Perumal Samy R; Gopalakrishnakone P; Ho B; Chow VT
Biochimie; 2008 Sep; 90(9):1372-88. PubMed ID: 18472013
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
9. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
Zhan C; Li S; Zhong Q; Zhou D
Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
[TBL] [Abstract][Full Text] [Related]
10. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
11. An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo.
Jiang M; Yang X; Wu H; Huang Y; Dou J; Zhou C; Ma L
Biochem Pharmacol; 2020 Feb; 172():113746. PubMed ID: 31812678
[TBL] [Abstract][Full Text] [Related]
12. Recombinant antitoxic and antiinflammatory factor from the nonvenomous snake Python reticulatus: phospholipase A2 inhibition and venom neutralizing potential.
Thwin MM; Gopalakrishnakone P; Kini RM; Armugam A; Jeyaseelan K
Biochemistry; 2000 Aug; 39(31):9604-11. PubMed ID: 10924158
[TBL] [Abstract][Full Text] [Related]
13. Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria.
Tram NDT; Selvarajan V; Boags A; Mukherjee D; Marzinek JK; Cheng B; Jiang ZC; Goh P; Koh JJ; Teo JWP; Bond PJ; Ee PLR
Acta Biomater; 2021 Nov; 135():214-224. PubMed ID: 34506975
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
15. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides.
Zhou C; Qi X; Li P; Chen WN; Mouad L; Chang MW; Leong SS; Chan-Park MB
Biomacromolecules; 2010 Jan; 11(1):60-7. PubMed ID: 19957992
[TBL] [Abstract][Full Text] [Related]
16. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS).
Fisher AB; Dodia C; Chatterjee S; Feinstein SI
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096551
[TBL] [Abstract][Full Text] [Related]
17. Venom neutralization by purified bioactive molecules: Synthetic peptide derivatives of the endogenous PLA(2) inhibitory protein PIP (a mini-review).
Thwin MM; Samy RP; Satyanarayanajois SD; Gopalakrishnakone P
Toxicon; 2010 Dec; 56(7):1275-83. PubMed ID: 20045432
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
19. A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A(2) inhibitor, displays antitumour activity.
Donnini S; Finetti F; Francese S; Boscaro F; Dani FR; Maset F; Frasson R; Palmieri M; Pazzagli M; De Filippis V; Garaci E; Ziche M
Biochem J; 2011 Dec; 440(2):251-62. PubMed ID: 21834793
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.
Weinrauch Y; Abad C; Liang NS; Lowry SF; Weiss J
J Clin Invest; 1998 Aug; 102(3):633-8. PubMed ID: 9691100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
